Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2023-06-28

EMA Authorised: Luminity (perflutren) — Lantheus EU Limited

View source ↗

Summary

Luminity (perflutren) has authorisation in the EU for use in echocardiography.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Luminity (perflutren)

Snippet

Status: Authorised. Therapeutic area: Echocardiography. MAH: Lantheus EU Limited. Decision date: 01/06/2023